{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:07:40Z","timestamp":1793210860451,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HC23C0249"],"award-info":[{"award-number":["HC23C0249"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.mayocp.2024.11.028","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T04:03:00Z","timestamp":1746072180000},"page":"801-813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk of Autoimmune Rheumatic Diseases in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Nationwide Cohort Study in South Korea"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5578-7571","authenticated-orcid":false,"given":"Soonwook","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-1263","authenticated-orcid":false,"given":"Kyung-Do","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8920-8777","authenticated-orcid":false,"given":"Jin Hyung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2021-8587","authenticated-orcid":false,"given":"Eun Bin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3780-6844","authenticated-orcid":false,"given":"Junhee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0758-2627","authenticated-orcid":false,"given":"Yeonghee","family":"Eun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3036-7332","authenticated-orcid":false,"given":"Hyungjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7052-2432","authenticated-orcid":false,"given":"Yeon Hak","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8128-8920","authenticated-orcid":false,"given":"Dong Wook","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7338-9067","authenticated-orcid":false,"given":"Ju-Hong","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10422","key":"10.1016\/j.mayocp.2024.11.028_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","article-title":"Multiple sclerosis","volume":"403","author":"Jakimovski","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.028_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.mayocp.2024.11.028_bib3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1177\/1352458508088936","article-title":"Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark","volume":"14","author":"Nielsen","year":"2008","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.mayocp.2024.11.028_bib4","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S1474-4422(07)70132-1","article-title":"Autoimmune disease in families with multiple sclerosis: a population-based study","volume":"6","author":"Ramagopalan","year":"2007","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.mayocp.2024.11.028_bib5","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1468-1331.2010.02971.x","article-title":"Comorbidities amongst patients with multiple sclerosis: a population-based controlled study","volume":"17","author":"Kang","year":"2010","journal-title":"Eur J Neurol"},{"issue":"26","key":"10.1016\/j.mayocp.2024.11.028_bib6","doi-asserted-by":"crossref","first-page":"e3999","DOI":"10.1097\/MD.0000000000003999","article-title":"Increased incidence of rheumatoid arthritis in multiple sclerosis: a nationwide cohort study","volume":"95","author":"Tseng","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"14","key":"10.1016\/j.mayocp.2024.11.028_bib7","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.0000000000002481","article-title":"CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis. Sex differences in comorbidity at diagnosis of multiple sclerosis: a population-based study","volume":"86","author":"Marrie","year":"2016","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.mayocp.2024.11.028_bib8","first-page":"4066","article-title":"A\u00a0global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications","volume":"268","author":"Hauer","year":"2021","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.mayocp.2024.11.028_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.msard.2018.11.008","article-title":"Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review","volume":"27","author":"Shahmohammadi","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.028_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10067-023-06809-z","article-title":"Nationwide analysis of neuromyelitis optica in systemic lupus erythematosus and Sjogren's syndrome","volume":"43","author":"Sami","year":"2024","journal-title":"Clin Rheumatol"},{"issue":"48","key":"10.1016\/j.mayocp.2024.11.028_bib11","doi-asserted-by":"crossref","first-page":"e13100","DOI":"10.1097\/MD.0000000000013100","article-title":"A\u00a0multi-facet comparative analysis of neuromyelitis optica spectrum disorders in patients with seropositive and seronegative AQP4-IgG","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.028_bib12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/jamainternmed.2015.7110","article-title":"Korean National Health Insurance Database","volume":"176","author":"Shin","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.028_bib13","first-page":"799","article-title":"Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea","volume":"46","author":"Cheol Seong","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"6","key":"10.1016\/j.mayocp.2024.11.028_bib14","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \"McDonald Criteria.\"","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.mayocp.2024.11.028_bib15","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mayocp.2024.11.028_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.mayocp.2024.11.028_bib17","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1177\/1352458519888609","article-title":"Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea","volume":"26","author":"Kim","year":"2020","journal-title":"Mult Scler"},{"key":"10.1016\/j.mayocp.2024.11.028_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2022-329389","article-title":"Risk of Parkinson's disease in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide cohort study in South Korea","author":"Kwon","year":"2022","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mayocp.2024.11.028_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1214652","article-title":"The risk of dementia in multiple sclerosis and neuromyelitis optica spectrum disorder","volume":"17","author":"Cho","year":"2023","journal-title":"Front Neurosci"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.028_bib20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3904\/kjim.2018.303","article-title":"Trend of prevalence and incidence of systemic lupus erythematosus in South Korea, 2005\u00a0to 2015: a nationwide population-based study","volume":"35","author":"Bae","year":"2020","journal-title":"Korean J Intern Med"},{"issue":"9","key":"10.1016\/j.mayocp.2024.11.028_bib21","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/rheumatology\/kead048","article-title":"Familial risk of seropositive rheumatoid arthritis and interaction with smoking: a population-based cohort study","volume":"62","author":"Kim","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.mayocp.2024.11.028_bib22","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/1756-185X.13927","article-title":"Risk of malignancy in Korean patients with primary Sjogren's syndrome","volume":"23","author":"Kang","year":"2020","journal-title":"Int J Rheum Dis"},{"issue":"8","key":"10.1016\/j.mayocp.2024.11.028_bib23","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.3346\/jkms.2019.34.e55","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies in Korea: a nationwide population-based study","volume":"34","author":"Cho","year":"2019","journal-title":"J\u00a0Korean Med Sci"},{"issue":"7","key":"10.1016\/j.mayocp.2024.11.028_bib24","doi-asserted-by":"crossref","first-page":"e0200363","DOI":"10.1371\/journal.pone.0200363","article-title":"Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients","volume":"13","author":"Yang","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.028_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000514634","article-title":"Beh\u00e7et's disease is associated with multiple sclerosis and rheumatoid arthritis: a Korean population-based study","volume":"238","author":"Jung","year":"2022","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.mayocp.2024.11.028_bib26","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.3346\/jkms.2020.35.e35","article-title":"Epidemiology of antiphospholipid syndrome in Korea: a nationwide population-based study","volume":"35","author":"Hwang","year":"2020","journal-title":"J\u00a0Korean Med Sci"},{"issue":"2","key":"10.1016\/j.mayocp.2024.11.028_bib27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/mds.27922","article-title":"Body mass index, diabetes, and the risk of Parkinson's disease","volume":"35","author":"Jeong","year":"2020","journal-title":"Mov Disord"},{"key":"10.1016\/j.mayocp.2024.11.028_bib28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.phrs.2018.01.009","article-title":"Metabolic syndrome, autoimmunity and rheumatic diseases","volume":"133","author":"Medina","year":"2018","journal-title":"Pharmacol Res"},{"issue":"11","key":"10.1016\/j.mayocp.2024.11.028_bib29","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1136\/annrheumdis-2014-205216","article-title":"Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study","volume":"74","author":"Kim","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2024.11.028_bib30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoimmune disease: from protein prenylation to immunomodulation","volume":"6","author":"Greenwood","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.mayocp.2024.11.028_bib31","article-title":"Th17 cells pathways in multiple sclerosis and neuromyelitis optica spectrum disorders: pathophysiological and therapeutic implications","volume":"2016","author":"Dos Passos","year":"2016","journal-title":"Mediators Inflamm"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.028_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","article-title":"Beh\u00e7et's disease, the Silk Road and HLA-B51: historical and geographical perspectives","volume":"54","author":"Verity","year":"1999","journal-title":"Tissue Antigens"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.028_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2251-6581-13-18","article-title":"Vitamin D deficiency in patients with Beh\u00e7et's disease","volume":"13","author":"Faezi","year":"2014","journal-title":"J\u00a0Diabetes Metab Disord"},{"issue":"4","key":"10.1016\/j.mayocp.2024.11.028_bib34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/14397595.2018.1493065","article-title":"Cigarette smoking and risk of Beh\u00e7et's disease: a propensity score matching analysis","volume":"29","author":"Malek Mahdavi","year":"2019","journal-title":"Mod Rheumatol"},{"issue":"6, suppl 121","key":"10.1016\/j.mayocp.2024.11.028_bib35","first-page":"58","article-title":"Microbiota stratification identifies disease-specific alterations in neuro-Beh\u00e7et's disease and multiple sclerosis","volume":"37","author":"Oezguen","year":"2019","journal-title":"Clin Exp Rheumatol"},{"issue":"6, suppl 94","key":"10.1016\/j.mayocp.2024.11.028_bib36","first-page":"S80","article-title":"Beh\u00e7et's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria","volume":"33","author":"Akman-Demir","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.mayocp.2024.11.028_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-Barr virus and systemic autoimmune diseases","volume":"11","author":"Houen","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.028_bib38","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1352458514564490","article-title":"A\u00a0systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.028_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41584-023-01057-6","article-title":"Epidemiology of Sj\u00f6gren syndrome","volume":"20","author":"Beydon","year":"2024","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.mayocp.2024.11.028_bib40","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ng1544","article-title":"MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction","volume":"37","author":"Swanberg","year":"2005","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.mayocp.2024.11.028_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122271","article-title":"TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits","volume":"10","author":"Diogo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mayocp.2024.11.028_bib42","article-title":"The causal relationship between neuromyelitis optica spectrum disorder and other autoimmune diseases","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.mayocp.2024.11.028_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11910-021-01124-z","article-title":"Neurologic manifestations of the antiphospholipid syndrome \u2013 an update","volume":"21","author":"Leal Rato","year":"2021","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.028_bib44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1212\/WNL.0000000000002208","article-title":"Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"86","author":"Nour","year":"2016","journal-title":"Neurology"},{"issue":"1-2","key":"10.1016\/j.mayocp.2024.11.028_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jneuroim.2010.11.010","article-title":"Enhanced complement consumption in neuromyelitis optica and Beh\u00e7et's disease patients","volume":"233","author":"T\u00fcz\u00fcn","year":"2011","journal-title":"J\u00a0Neuroimmunol"},{"issue":"6","key":"10.1016\/j.mayocp.2024.11.028_bib46","first-page":"e26138","article-title":"Neuromyelitis optica spectrum disorder and autoimmune rheumatological diseases: a report of two cases and literature review","volume":"14","author":"Faisal","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.028_bib47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica\u00a0and non organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1016\/j.mayocp.2024.11.028_bib48","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamaneurol.2014.775","article-title":"Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum","volume":"71","author":"Guo","year":"2014","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.028_bib49","first-page":"4","article-title":"Drug-induced systemic lupus erythematosus in interferon beta-1b therapy","volume":"32","author":"Sladkova","year":"2011","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.mayocp.2024.11.028_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102589","article-title":"Systemic erythematous lupus after treatment of multiple sclerosis with alemtuzumab","volume":"46","author":"Adamec","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"10.1016\/j.mayocp.2024.11.028_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11910-017-0742-1","article-title":"CNS demyelination with TNF-\u03b1 blockers","volume":"17","author":"Kemanetzoglou","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.028_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.intimp.2008.10.004","article-title":"A\u00a0review of the current use of rituximab in autoimmune diseases","volume":"9","author":"G\u00fcrcan","year":"2009","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"10.1016\/j.mayocp.2024.11.028_bib53","first-page":"7525","article-title":"Aquaporin4-IgG seropositivity significantly increases the risk of comorbid autoimmune diseases in NMOSD patients: population-based registry data","volume":"271","author":"Pekmezovic","year":"2024","journal-title":"J\u00a0Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.028_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.59578\/jmsni.2023.14.1.51","article-title":"Multiple sclerosis in Korea: a hospital-based, multicenter, epidemiological study","volume":"14","author":"Kim","year":"2023","journal-title":"J\u00a0Mult Scler Neuroimmunol"},{"issue":"6","key":"10.1016\/j.mayocp.2024.11.028_bib55","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.it.2011.03.008","article-title":"Interferon-\u03b2 exacerbates Th17-mediated inflammatory disease","volume":"32","author":"Axtell","year":"2011","journal-title":"Trends Immunol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619624006645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619624006645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:40:12Z","timestamp":1762213212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619624006645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0025619624006645"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2024.11.028","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Autoimmune Rheumatic Diseases in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Nationwide Cohort Study in South Korea","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2024.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}